Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease

被引:52
|
作者
Gosselet, Fabien
Saint-Pol, Julien
Fenart, Laurence
机构
[1] Univ Lille Nord France, Lille, France
[2] UArtois, LBHE, EA 2465, Lens, France
[3] IMPRT IFR114, Lille, France
关键词
Oxysterols; Blood-brain barrier; ABCA1; ABCB1; Alzheimer's disease; LXR; CAPILLARY ENDOTHELIAL-CELLS; AMYLOID-BETA-PEPTIDE; BODY CHOLESTEROL METABOLISM; TO-BASOLATERAL TRANSPORT; TRANSGENIC MOUSE MODEL; P-GLYCOPROTEIN; IN-VITRO; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATIVE DISEASES;
D O I
10.1016/j.bbrc.2013.11.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered brain cholesterol homeostasis plays a key role in neurodegenerative diseases such as Alzheimer's disease (AD). For a long time, the blood-brain barrier (BBB) was basically considered as a barrier isolating the brain from circulating cholesterol, however, several lines of evidence now suggest that the BBB strictly regulates the exchanges of sterol between the brain and the peripheral circulation. Oxysterols, synthesized by neurons or by peripheral cells, cross the BBB easily and modulate the expression of several enzymes, receptors and transporters which are involved not only in cholesterol metabolism but also in other brain functions. This review article deals with the way oxysterols impact BBB cells. These perspectives open new routes for designing certain therapeutical approaches that target the BBB so that the onset and/or progression of brain diseases such as AD may be modulated. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 50 条
  • [31] Alzheimer's disease drug development and the problem of the blood-brain barrier
    Pardridge, William A.
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 427 - 432
  • [32] Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer's disease
    Lee, Rae-Ling
    Funk, Kristen E.
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [33] Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target
    Liu, Shan
    Gao, Jiguo
    Liu, Kangding
    Zhang, Hong-Liang
    MECHANISMS OF AGEING AND DEVELOPMENT, 2021, 199
  • [34] The Case for Blood-Brain Barrier Dysfunction in the Pathogenesis of Alzheimer's Disease
    Jeynes, Brian
    Provias, John
    JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (01) : 22 - 28
  • [35] Blood-Brain Barrier Leakage in Early Alzheimer Disease
    Lecler, Augustin
    Fournier, Laure
    Diard-Detoeuf, Capucine
    Balvay, Daniel
    RADIOLOGY, 2017, 282 (03) : 923 - 924
  • [36] Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: A physical and conceptual challenge
    Hachinski, Vladimir
    Lee, Ting-Yim
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 435 - 436
  • [37] Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer's disease?
    Petrovskaya, Aleksandra
    Tverskoi, Artem
    Medvedeva, Angela
    Nazarova, Maria
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [38] Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?
    Aleksandra Petrovskaya
    Artem Tverskoi
    Angela Medvedeva
    Maria Nazarova
    Communications Biology, 6
  • [39] The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
    Pan, Yijun
    Khalil, Hanan
    Nicolazzo, Joseph A.
    CURRENT CLINICAL PHARMACOLOGY, 2015, 10 (03): : 222 - 241
  • [40] Effective blood-brain barrier transporter developed for Alzheimer's disease drugs
    Heseltine, Phoebe
    NANOMEDICINE, 2014, 9 (02) : 186 - 186